Literature DB >> 6208695

Recombinant DNA in medicine.

S D Cederbaum, G C Fareed, M A Lovett, L J Shapiro.   

Abstract

Studies in bacteria and bacterial viruses have led to methods to manipulate and recombine DNA in unique and reproducible ways and to amplify these recombined molecules millions of times. Once properly identified, the recombinant DNA molecules can be used in various ways useful in medicine and human biology. There are many applications for recombinant DNA technology. Cloned complementary DNA has been used to produce various human proteins in microorganisms. Insulin and growth hormone have been extensively and successfully tested in humans and insulin has been licensed for sale. Mass production of bacterial and viral antigens with recombinant DNA technology is likely to provide safe and effective vaccines for some disorders for which there is no prevention. The cloned probes for the human alpha- and beta-globin loci, for specific disease genes, such as the Z allele of alpha-antitrypsin, and for random genomic sequences are proving useful for prenatally diagnosing human genetic disorders and preventing their clinical consequences.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208695      PMCID: PMC1021739     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  82 in total

1.  The antibody respones in man to infection with different serotypes of group-A streptococci.

Authors:  J P Widdowson; W R Maxted; C M Notley; A M Pinney
Journal:  J Med Microbiol       Date:  1974-11       Impact factor: 2.472

2.  Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

Authors:  J Lieberman
Journal:  N Engl J Med       Date:  1969-08-07       Impact factor: 91.245

3.  Isolation of rabbit reticulocyte 9 S mRNA.

Authors:  B Lebleu
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  A restriction enzyme from Hemophilus influenzae. I. Purification and general properties.

Authors:  H O Smith; K W Wilcox
Journal:  J Mol Biol       Date:  1970-07-28       Impact factor: 5.469

5.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Gene manipulation.

Authors:  S N Cohen
Journal:  N Engl J Med       Date:  1976-04-15       Impact factor: 91.245

7.  Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation.

Authors:  Y W Kan; A M Dozy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

8.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin.

Authors:  K Itakura; T Hirose; R Crea; A D Riggs; H L Heyneker; F Bolivar; H W Boyer
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

9.  New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8.

Authors:  D G Evans; D J Evans
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity.

Authors:  J F Hildebrandt; L W Mayer; S P Wang; T M Buchanan
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.